A new phase 3 trial showed that lung cancer patients who were treated with an immunotherapy in the morning had better overall survival than those who were treated in the afternoon. Your immune system has a circadian rhythm.

From Twitter
Disclaimer: The content above is only the author's opinion which does not represent any position of Followin, and is not intended as, and shall not be understood or construed as, investment advice from Followin.
Like
Add to Favorites
Comments
Share
Relevant content





